20096 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Nanocapsules of protamine
#2702Tetrahydrocarboline derivative
#2703cKIT antibody drug conjugates
#2704Formulation of human antibodies for treating TNF-α associated disorders
#2705Lipopeptide compositions and related methods
#2706COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER
#2707Formulation of an antibody and use thereof
#2708High purity oritavancin and method of producing same
#2709Spinal disc regenerative composition and method of manufacture and use
#2710Spinal disc regenerative composition and method of manufacture and use
#2711Spinal disc regenerative composition and method of manufacture and use
#2712Levothyroxine Formulations
#2713Cyclodextrin compositions encapsulating a selective ATP inhibitor and uses thereof
#2714USE OF DIANHYDROGALACTITOL AND ANALOGS OR DERIVATIVES THEREOF IN COMBINATION WITH PLATINUM-CONTAINING ANTINEOPLASTIC AGENTS TO TREAT NON-SMALL-CELL CARCINOMA OF THE LUNG AND BRAIN METASTASES
#2715Nanoparticles stabilized with nitrophenylboronic acid compositions
#2716Methods for producing a biodegradable chitosan composition and uses thereof
#2717Ceftolozane antibiotic compositions
#2718Factor IX polypeptide formulations
#2719Composition for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs
#2720Composition for gene delivery comprising chitosan and liquid crystal formation material
#2721Stable nocathiacin lyophilized injection agent
#2722Methods of treating spinal cord injury
#2723Process for making dry and stable hemostatic compositions
#2724HPPH lyophilized powder injection for injection and preparation method thereof
#2725Nanoparticles containing a Taxane and their Use
#2726Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy
#2727Freeze-dried composition
#2728Polypeptide porous body and method for producing same
#2729Enzyme responsive nanocapsules for protein delivery
#2730ANTIBODY FORMULATION
#2731Formulation of human antibodies for treating TNF-alpha associated disorders
#2732Formulation of human antibodies for treating TNF-alpha associated disorders
#2733Formulation of human antibodies for treating TNF-alpha associated disorders
#2734Formulation of human antibodies for treating TNF-alpha associated disorders
#2735Formulation of human antibodies for treating TNF-alpha associated disorders
#2736Lyophilized formulation comprising GM-CSF neutralizing compound
#2737Temperature Stable Vaccine Formulations
#2738Pharmaceutical formulations
#2739Lyophilized preparations of melphalan flufenamide
#2740Cabazitaxel composition
#2741Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
#2742REHYDRATABLE PHARMACEUTICAL PRODUCT
#2743Solid betalain compositions and methods
#2744Enhanced delivery of drug compositions to treat life threatening infections
#2745Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
#2746Rehydratable pharmaceutical product
#2747FREEZE-DRIED EXCIPIENT AND PREPARATION METHOD THEREOF
#2748Oral delivery for hemoglobin based oxygen carriers
#2749Daptomycin formulations and uses thereof
#2750SYN3 COMPOSITIONS AND METHODS
#2751Methods to treat, prevent, and improve skin conditions
#2752LYOPHILIZED SPHERICAL PELLETS OF ANTI-IL-23 ANTIBODIES
#2753Formulation of human antibodies for treating TNF-alpha associated disorders
#2754Reconstituted HDL formulation
#2755TAZOBACTAM ARGININE ANTIBIOTIC COMPOSITIONS
#2756Stable montelukast solution
#2757COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE
#2758COMPOSITIONS FOR THE RESTORATION OF A FECAL MICROBIOTA AND METHODS FOR MAKING AND USING THEM
#2759Lyophilization of synthetic liposomal pulmonary surfactant
#2760PHARMACEUTICAL COMPOSITION COMPRISING BENDAMUSTINE
#2761Targeting-enhanced anticancer nanoparticles and preparation methods of same
#2762PHARMACEUTICAL COMPOSITION
#2763NOVEL LYOPHILIZED COMPOSITIONS OF CYCLOPHOSPHAMIDE
#2764Pharmaceutical composition of tapentadol for parenteral administration
#2765PREPARATION METHOD OF POLYMERIC MICELLES COMPOSITION CONTAINING A POORLY WATER-SOLUBLE DRUG
#2766Stabilized antibody-containing formulations
#2767Amphiphilic block copolymer and preparation method thereof and micellar drug-loading system formed by same with antitumor drug
#2768Stable pharmaceutical composition of Etanercept in a phosphate citrate buffer with glycine as an anti-aggregating agent
#2769Induction of antigen-specific tolerance by peripheral phagocytosis
#2770Peptide conjugated particles
#2771Stabilized compositions of proteins having a free thiol moiety
#2772Stable formulations for lyophilizing therapeutic particles
#2773Compositions containing cyclic peptides and methods of use
#2774Composition for cosmetic, pharmaceutical and dietary applications
#2775Bendamustine solid dispersions and continuous infusion
#2776Melatonin-based formulations for parenteral administration
#2777Virus-containing formulation and use thereof
#2778Compositions for rapidly treating severe hypoglycemia
#2779Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
#2780METHOD FOR TREATING BONE LOSS USING PARATHYROID HORMONE
#2781Probiotic recolonisation therapy
#2782Microbiota restoration therapy (MRT), compositions and methods of manufacture
#2783Bio-available N-acetyl creatine species and compositions thereof
#2784Therapeutic composition with a botulinum neurotoxin
#2785Veterinary composition and methods for non-surgical neutering and castration
#2786Lyophilized viral formulations
#2787Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
#2788Method for freeze drying a bacteria-containing concentrate
#2789Polypeptide and lipophilic moiety conjugate compositions, formulations, and uses related thereto
#2790Stabilizing alkylglycoside compositions and methods thereof
#2791Chitosan materials from carbonic acid solution
#2792Encapsulation system
#2793SYSTEMS, METHODS AND COMPOSITIONS FOR IMPROVED TREATMENT OF ACIDOSIS
#2794System and method for multiphasic release of growth factors
#2795Pharmaceutical formulations for the treatment of pulmonary arterial hypertension
#2796CONTROL OF FREEZING AND THAWING OF DRUG SUBSTANCES USING HEAT FLOW CONTROL
#2797Tigecycline composition for injection
#2798Peptide conjugated particles
#2799Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
#2800ANNELID HAEMOGLOBIN LYOPHILISATION PROCESS
#2801Pharmaceutical compositions
#2802Levothyroxine formulations
#2803Levothyroxine formulations
#2804INSULIN-PRAMLINTIDE COMPOSITIONS AND METHODS FOR MAKING AND USING THEM
#2805Method for treating a lung tumor in a subject in need thereof
#2806Methods of treating arthritis
#2807Process for producing cell culture media
#2808Use of polymeric excipients for lyophilization or freezing of particles
#2809Proliposomal testosterone formulations
#2810Method of double-coating lactic acid bacteria
#2811Crystalline forms of a biphenyl compound
#2812Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve
#2813TREATMENT METHOD USING SOLID AMORPHOUS PARTICLES COMPRISING TIOTROPIUM BROMIDE AND A CO-SOLID
#2814Antioxidant stabilized pharmaceutical formulations comprising antineoplastic compounds
#2815Nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine and uses thereof
#2816Cochleates made with soy phosphatidylserine
#2817Ophthalmic drug delivery system containing phospholipid and cholesterol
#2818Formulations and methods for lyophilization and lyophilates provided thereby
#2819Trigger-responsive chain-shattering polymers
#2820Tigecycline compositions and methods of preparation
#2821Manufacture of degarelix
#2822METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT
#2823Cochleates made with soy phosphatidylserine
#2824Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase
#2825Directional freezing
#2826Branched chain amino acids: formulations and methods of treatment
#2827Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
#2828Highly penetrative nanocarriers for treatment of CNS disease
#2829Bioactive compounds protection method and compositions containing the same
#2830Pharmaceutical compositions comprising pemetrexed and tromethamine
#2831METHOD OF DOUBLE-COATING LACTIC ACID BACTERIA
#2832Composition for gene delivery
#2833Line leaf inula flower lactone A and methods for preparing and using the same for treating multiple sclerosis
#2834Pharmaceutical formulations of ecteinascidin compounds
#2835Formulation of human antibodies for treating TNF-α associated disorders
#2836Polycarbonate containing compounds and methods related thereto
#2837Bendamustine HCL Stable Lyophilized Formulations
#2838Dosing regimens for echinocandin class compounds
#2839Highly concentrated pharmaceutical formulations
#2840Medicaments and methods for treating cancer
#2841Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
#2842Sustained-release composition and method for producing the same
#2843PROTEIN STABILIZATION FORMULATIONS
#2844Stable liquid formulations of dimer VEGF antagonists
#2845Antibody formulations and methods
#2846Formulations of recombinant furin
#2847Polymeric nanocarriers with linear dual response mechanism
#2848Tazobactam Arginine Compositions
#2849Caspofungin composition
#2850Pharmaceutical formulations of TNF-alpha antibodies
#2851Liquid pharmaceutical formulations for injection comprising procaine and uses thereof
#2852Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof
#2853Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof
#2854Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof
#2855Treatment of huntington'S disease
#2856Therapeutic agent for disc herniation
#2857Compositions Containing Probiotics and a Beepollen/Clay Complex, Preparation Method Thereof and Uses of Same in Nutrition and Therapeutics
#2858Stabilized statin formulations
#2859Lyophilized preparation of botulinum toxin
#2860Pharmaceutical compounds
#2861Application of depolymerized holothurian glycosaminoglycans (DHG) in preparation of drug for prevention and treatment of thromboembolic diseases
#2862Method for peroral delivery of insulin and its analogues for therapeutic usage
#2863Microbiota restoration therapy (MRT), compositions and methods of manufacture
#2864TAZOBACTAM AND CEFTOLOZANE ANTIBIOTIC COMPOSITIONS
#2865Fast dissolving pharmaceutical composition
#2866Reduced-viscosity concentrated protein formulations
#2867Antiviral methods and compositions comprising probiotic bacterial molecules
#2868Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
#2869Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
#2870Dry glassy composition comprising a bioactive material
#2871Methods and compositions for stabilizing dried biological materials
#2872Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#2873Use of oligomers of lactic acid in the treatment of gynaecological disorders
#2874Keratin compositions comprising halofuginone
#2875Albumin-free factor VIII formulations
#2876Controlled release sterile injectable aripiprazole formulation and method
#2877Anti-TNF antibody formulations
#2878Liquid vaccines for multiple meningococcal serogroups
#2879Stabilized formulations of peptides and proteins protecting against non-enzymatic degradation
#2880Lyophilized formulations of bendamustine hydrochloride
#2881Composition for inhibiting after-cataract and method of preparing the same
#2882Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis
#2883Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
#2884Formulation for anti-α4β7 antibody
#2885Methods and compositions for tissue regeneration
#2886Arsenic compound solution and albumin nanoparticle and lyophilized preparation entrapping arsenic compound prepared using same
#2887Lipopeptide compositions and related methods
#2888Pastes for injection of a therapeutic agent
#2889Drug loaded polymeric nanoparticles and methods of making and using same
#2890Formulations for the treatment of diabetes
#2891METHOD FOR MAKING PRECIPITATED PARTICLES
#2892Macrolide particulates, methods for preparation, and medical devices associated therewith
#2893Aqueous compositions comprising arbekacin
#2894Daidzein derivative, pharmaceutically acceptable salt and preparation method thereof, and pharmaceutical composition containing same
#2895Compositions and methods for decreasing the effects of alcohol
#2896Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
#2897Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
#2898VEGF antagonist formulations for intravitreal administration
#2899Process to prepare a stable thrombin composition
#2900Formulation of human antibodies for treating TNF-alpha associated disorders
#2901Formulation of human antibodies for treating TNF-α associated disorders
#2902Cross-linked compositions
#2903Stabilized pharmaceutical formulations comprising antineoplastic compounds
#2904COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL
#2905Drug formulations
#2906Dihydropyrazoles
#2907Microsphere drug delivery system for sustained intraocular release
#2908Stabilisation of polypeptides
#2909Method for nucleic acid delivery using hyaluronic acid
#2910Cleavable lipids
#2911COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS
#2912Injectable ropinirole compositions and methods for making and using same
#2913Stabilized pharmaceutical formulations comprising antineoplastic compounds
#2914Voriconazole Formulations
#2915Ceftolozane-tazobactam pharmaceutical compositions
#2916CEPHALOSPORIN PHARMACEUTICAL COMPOSITIONS
#2917TAZOBACTAM AND CEFTOLOZANE ANTIBIOTIC COMPOSITIONS
#2918CEFTOLOZANE PHARMACEUTICAL COMPOSITIONS
#2919Diketopiperazine microparticles with defined specific surface areas
#2920Bioerodible silicon-based compositions for delivery of therapeutic agents
#2921Formulation of an antibody and use thereof
#2922Methods and compositions for CNS delivery of iduronate-2-sulfatase
#2923Ceftolozane-tazobactam pharmaceutical compositions
#2924Method of lyophilizing liposomes
#2925Hybrid polypeptides with selectable properties
#2926Nanoparticles stabilized with nitrophenylboronic acid compositions
#2927STABLE LYOPHILIZED PHARMACEUTICAL PREPARATIONS OF MONOCLONAL OR POLYCLONAL ANTIBODIES
#2928Stable pharmaceutical formulations of methylnaltrexone
#2929PRAME PURIFICATION
#2930Stable formulations of antibodies to human programmed death receptor PD-1 and related treatments
#2931DRY POWDER COMPOUND FORMULATIONS AND USES THEREOF
#2932Low impurity content caspofungin preparation, method for preparing same, and use thereof
#2933Methods and compositions for delivery of exogenous factors to nervous system sites
#2934Formulation for preventing or reducing bleeding at a surgical site
#2935Stabilizing agent for pharmaceutical proteins
#2936Methods for rapidly treating severe hypoglycemia
#2937Low impurity content caspofungin preparation, method for preparing same, and use thereof
#2938PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII ENCAPSULATED IN MICELLES
#2939Compositions of lopinavir and ritonavir
#2940Compositions of efavirenz
#2941Stabilized compositions of proteins having a free thiol moiety
#2942Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
#2943Taxane silicate prodrugs and nanoparticles
#2944Composition containing S-adenosyl-L-methionine with excellent storage stability
#2945Compositions of lopinavir
#2946COMPOSITIONS AND METHODS FOR REPAIRING BONE
#2947Method of preparing carrier liquids
#2948Solid dispersions of amorphous paroxetine mesylate
#2949Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same
#2950Anti-BAFFR antibody formulations
#2951Stable formulations for parenteral injection of peptide drugs
#2952Stable formulations for parenteral injection of peptide drugs
#2953Stabilized liquid and lyophilized ADAMTS13 formulations
#2954Stable glucagon formulations for the treatment of hypoglycemia
#2955Stable formulations for parenteral injection of peptide drugs
#2956Composition and method for treating HPV
#2957Polymeric delivery systems for active agents
#2958LYOPHILIZED FORMULATION OF TAT-NR2B9C
#2959Pharmaceutical compositions of dextran polymer derivatives
#2960Process for forming amorphous atorvastatin
#2961Thrombin solution and methods of use thereof
#2962Process for stabilizing an adjuvant containing vaccine composition
#2963FOR INJECTABLE FORMULATIONS CONTAINING ASENAPINE AND METHOD OF TREATMENT USING SAME
#2964BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
#2965Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
#2966Caspofungin acetate formulations
#2967Anti-fatty liver agent
#2968Tannin-chitosan composites
#2969Formulation of human antibodies for treating TNF-α associated disorders
#2970Freeze-dried formulations of FGF-18
#2971Desiccated biologics and methods of preparing the same
#2972COMPOSITION FOR COSMETIC, PHARMACEUTICAL AND DIETARY APPLICATIONS
#2973Freeze-dried aripiprazole formulation
#2974Proliposomal testosterone formulations
#2975Methods of treating, reducing the incidence of, and/or preventing ischemic events
#2976Therapeutic composition with a botulinum neurotoxin
#2977IFN-beta compositions, preparation methods and uses thereof
#2978System and method for multiphasic release of growth factors
#2979Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide
#2980Pharmaceutical composition
#2981Lyophilization of synthetic liposomal pulmonary surfactant
#2982Lyophilization of synthetic liposomal pulmonary surfactant
#2983FREEZE-DRIED PREPARATION CONTAINING HIGH-PURITY PTH AND METHOD FOR PRODUCING SAME
#2984Methods for the preparation of liposomes comprising drugs
#2985Formulation of human antibodies for treating TNF-alpha associated disorders
#2986Formulation of human antibodies for treating TNF-α associated disorders
#2987Lyophilized preparation of botulinum toxin
#2988Bendamustine formulations
#2989Polycarbonates bearing pendant primary amines for medical applications
#2990Risperidone sustained release microsphere composition
#2991Diketopiperazine microparticles with defined specific surface areas
#2992Botulinum toxin compositions
#2993Compositions and methods of delivery of pharmacological agents
#2994Compositions and methods of delivery of pharmacological agents
#2995Freeze Dried Drug Nanosuspensions
#2996Nanoparticles loaded with chemotherapeutic antitumoral drug
#2997Glycopeptide phosphonate derivatives
#2998Nanocapsules with a polymer shell
#2999Microencapsulated probiotic substance and process of manufacture
#3000Tetrahydrocarboline derivative